Status:
UNKNOWN
Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
18-75 years
Brief Summary
Chronic viral hepatitis C is a frequent liver disease. It is associated with variable degree of hepatic fibrosis. To date, liver histology is still regarded as the gold standard to detect, diagnose an...
Eligibility Criteria
Inclusion
- alteration of liver function tests (ALT, AST)
- HCV RNA positive
Exclusion
- clotting disorder
- ongoing treatment with anti-coagulant or anti-aggregant
- advanced or decompensated cirrhosis (Child-Pugh class C)
- hepatocellular carcinoma
- other cancer
- history of surgery for brain aneurysm
- pace maker or defibrillator
- ocular metal foreign body
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00399815
Start Date
June 1 2006
End Date
May 1 2010
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires StLuc, Université catholique de Louvain (UCL)
Brussels, Belgium, 1200